Pds Biotechnology Corp (PDSB)

Jun 15, 2026

PDS Biotechnology Closes Financing and Retires Convertible Debentures - TipRanks

Jun 15, 2026

Jun 15, 2026

PDS Biotechnology (NASDAQ: PDSB) launches $50M ATM program tied to YA II financing - Stock Titan

Jun 15, 2026

Jun 15, 2026

[PRE 14A] PDS Biotechnology Corp Preliminary Proxy Statement - Stock Titan

Jun 15, 2026

Jun 15, 2026

PDS Biotechnology (NASDAQ: PDSB) adds $6M note and $50M at-the-market stock program - Stock Titan

Jun 15, 2026

Jun 15, 2026

PDS Biotechnology schedules 2026 annual meeting for Aug. 10; stockholder proposal deadline set - TradingView

Jun 15, 2026

Jun 15, 2026

PDS Biotechnology (PDSB) schedules 2026 annual meeting and sets June 25 proposal cutoff - Stock Titan

Jun 15, 2026

Jun 12, 2026

Here's Why PDS Biotechnology (PDSB) Could be Great Choice for a Bottom Fisher - MSN

Jun 12, 2026

Jun 10, 2026

Should I buy PDS Biotechnology (PDSB) - Zacks Investment Research

Jun 10, 2026

Jun 07, 2026

PDS Biotechnology Corporation - MLQ.ai

Jun 07, 2026

Jun 03, 2026

PDS Biotechnology Stock Gets Nasdaq Extension as Traders Eye PDSB - Bez Kabli

Jun 03, 2026

Jun 02, 2026

PDS Biotechnology (NASDAQ: PDSB) back in compliance with Nasdaq $1.00 bid rule - Stock Titan

Jun 02, 2026

May 28, 2026

PDS Biotechnology (PDSB) Slides 3.6% as Stock Tests Key Support Near $1.02Breakaway Gap - The Legal Advocate

May 28, 2026

May 27, 2026

PDSB Q4 2025 Earnings Call Transcript - Yahoo Finance

May 27, 2026

May 27, 2026

PDS Biotechnology Q1 2026 Earnings: EPS Beat on Narrower Loss, Clinical Progress in FocusReturn On Capital - Newser

May 27, 2026

May 25, 2026

PDS Biotechnology Q1 2026 Earnings: Narrowed Loss Per Share and Clinical Progress Drive Positive Market ResponseGrowth Acceleration Report - thelegaladvocate.com

May 25, 2026

May 24, 2026

PDS Biotechnology Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock Up 3.45%Earnings Growth Forecast - Newser

May 24, 2026

May 23, 2026

PDS Biotechnology Q1 2026 Earnings: EPS Beat Highlights Progress Despite Pre-Revenue StatusEarnings Forecast Report - newsline.com

May 23, 2026

May 19, 2026

PDS (PDSB) Q1 2026 Beat: Revenue $N/A, EPS Exceeds by SignificantPositive Surprise Momentum - The Legal Advocate

May 19, 2026

May 18, 2026

ETFs Investing in PDS Biotechnology Corp. Stocks - TradingView

May 18, 2026

May 18, 2026

PDS Biotechnology Q1 2026 earnings preview - MSN

May 18, 2026

May 16, 2026

Number of shareholders of PDS Biotechnology Corp. – SWB:EU6 - TradingView

May 16, 2026

May 15, 2026

PDS Biotechnology: Juni-Test für Wandelanleihe - kapitalmarktexperten.de

May 15, 2026

May 15, 2026

PDSB Stock Price, Quote & Chart | PDS BIOTECHNOLOGY CORP (NASDAQ:PDSB) - ChartMill

May 15, 2026

May 14, 2026

PDS Biotechnology Corp reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2026

May 14, 2026

PDS Biotechnology (PDSB) posts Q1 2026 loss and plans costly debt redemption - Stock Titan

May 14, 2026

May 14, 2026

PDS Biotechnology Q1 2026 Earnings Call: Complete Transcript - Sahm

May 14, 2026

May 13, 2026

PDS Biotech outlines VERSATILE-003 amendment targeting interim PFS with approximately 250 patients - MSN

May 13, 2026

May 13, 2026

PDSB Q1 2026 Earnings Transcript - AOL.com

May 13, 2026

May 13, 2026

PDS Biotechnology Q1 Earnings Call Highlights - MarketBeat

May 13, 2026

May 13, 2026

PDS Biotechnology Corporation Q1 2026 Earnings Call Summary - Yahoo Finance

May 13, 2026

May 13, 2026

PDS Biotech Reports Q1 2026 Financial Results, Highlights Clinical Progress in Cancer Immunotherapy Trials - Minichart

May 13, 2026

May 13, 2026

Earnings call transcript: PDS Biotechnology beats Q1 2026 EPS expectations By Investing.com - Investing.com South Africa

May 13, 2026

May 13, 2026

PDSB: Protocol changes accelerate clinical timelines and reduce costs, with improved financials - TradingView

May 13, 2026

May 13, 2026

Earnings call transcript: PDS Biotechnology beats Q1 2026 EPS expectations - Investing.com

May 13, 2026

May 13, 2026

PDS Biotech (NASDAQ:PDSB) Posts Narrower Q1 Loss, Pre-Market Rises Over 5% - ChartMill

May 13, 2026

May 13, 2026

PDS Biotechnology posts quarterly financial results and updates clinical programs - Traders Union

May 13, 2026

May 13, 2026

PDS BIOTECHNOLOGY ($PDSB) Releases Q1 2026 Earnings - Quiver Quantitative

May 13, 2026

May 13, 2026

PDS Biotechnology reports Q1 2026 net loss $7.3M, cash $21.7M; clinical updates on PDS0101 and PDS01ADC - TradingView

May 13, 2026

May 13, 2026

PDS Biotechnology Corporation Schedules Investor Webcast for Business and Clinical Update - Quiver Quantitative

May 13, 2026

May 13, 2026

PDS Biotechnology: Q1 Earnings Snapshot - marketscreener.com

May 13, 2026

May 13, 2026

PDSB: Q1 2026 featured clinical milestones, reduced net loss, and extended patent protection - TradingView

May 13, 2026

May 13, 2026

PDS Biotech (Nasdaq: PDSB) trims Q1 loss as R&D spending falls - Stock Titan

May 13, 2026

May 13, 2026

PDS Biotechnology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 13, 2026

May 13, 2026

PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update - marketscreener.com

May 13, 2026

May 13, 2026

PDS Biotech trial reports 77.8% response in colorectal cancer - Stock Titan

May 13, 2026

May 13, 2026

TradingKey - TradingKey

May 13, 2026

May 11, 2026

PDS Biotechnology Pushes Toward Pivotal Cancer Trial Results With Cash in Focus - AD HOC NEWS

May 11, 2026

May 11, 2026

PDS Biotechnology Corp expected to post a loss of 15 cents a shareEarnings Preview - TradingView

May 11, 2026

May 06, 2026

PDS Biotechnology to provide quarterly results and clinical program progress - Traders Union

May 06, 2026

May 06, 2026

PDS Biotech to Discuss First Quarter 2026 Financial Results on May 6th - geneonline.com

May 06, 2026

May 06, 2026

PDS Biotech to give Q1 results and clinical update May 13 - Stock Titan

May 06, 2026